- Bridging The Bias
- Posts
- Supreme Court Skeptical on Abortion Pill Access Challenge
Supreme Court Skeptical on Abortion Pill Access Challenge
Examining the Court's stance on a key abortion pill case amidst public debate
Sam Jordan
April 04, 2024
Supreme Court Skeptical on Abortion Pill Access Challenge
The U.S. Supreme Court appears skeptical in a hearing challenging access to the abortion pill, mifepristone. The case highlights the ongoing debate over abortion rights, amidst challenges from anti-abortion groups within & outside the Court. Also, this mifepristone case began 5 months after Roe v. Wade was overturned showing how tense this situation is.
But how has mainstream media been reporting this story?
What is the left saying?Many of the left believe the challenges aren’t properly backed from a legal standing: Solicitor General Elizabeth Prelogar, representing the Biden administration, pushed for the case's dismissal. She stated that the challengers don't have the legal standing to dispute the approval of mifepristone. …anti-abortion doctors and organizations don’t “Come within 100 miles” of having standing. Supporters highlighted the FDA's thorough research and data supporting mifepristone's safety and efficacy. They warned against undermining these evidence-based conclusions. Finally, concerns were raised about the challenge's broader impact on the FDA's drug approval — some claiming it undermines science. Since the overturning of Roe v. Wade, many are concerned this mifepristone case could impact the regulation of various medications in the future. | What is the right saying?The right, although generally against abortion, don’t think challenges are properly backed: Justice Amy Coney Barrett, appointed by former President Donald Trump, expressed doubts about the plaintiffs' standing. She noted their objections seemed focused on direct participation in abortions rather than the broader approval of mifepristone. “I think the difficulty here is that, at least to me, these affidavits do read more like the conscience objection is strictly to actually participating in the abortion to end the life of the embryo or fetus.” But of course, there were some challenges from the right. Abortion opponents turned to the FDA’s decision in 2016 & 2021 to relax restrictions were unreasonable. “…[it did] jeopardize women’s health across the nation.” But this looks unlikely to turn the Supreme Court, with a likely outcome being continued access to the pill. |
Let’s Seek Common Ground, What Are The Facts?
The Supreme Court seems likely to preserve access to a medication that was used in nearly two-thirds of all abortions in the U.S. last year
A consensus appeared to emerge that the abortion opponents who challenged the FDA’s approval of the medication, mifepristone, and subsequent actions to ease access to it, lack the legal right or standing to sue
A decision on this issue isn’t expected until June or July
News Worthy:
#1 — Building a new Key Bridge could take years and cost at least $400 million, experts say 🌉
#2 — US has agreed to send more bombs and warplanes to Israel, sources say 🪖
#3 — AT&T is investigating a leak that put millions of customers’ data on the dark web 🖥️
Personal Updates From Gen:
Next few videos are going to be insane! Currently working on a video where I interview a harvard doctor and two parents who unfortunately lost their kids to the internet…
And the next video will be on the hot topic of squatters…
Watch Our Latest Video:
Our goal with this newsletter is to battle mainstream media bias and give you the facts whilst highlighting news outlets’ bias. And we’d love to hear your thoughts! Please reply to this email telling us what you like about the newsletter!
Was this forwarded to you? Sign up here.
Want to advertise in Bridging The Bias? Go here.
Need YouTube advice? Ask Gen here.
